Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. | 45,000 | reported | 01 Oct 2025 | tx 1+45,000 |
| Monster Digital, Inc. | 41,077 | reported | 21 Apr 2023 | tx 3+1,350,177−9,100 |
| SUPERNUS PHARMACEUTICALS, INC. | 0 | reported | 19 Feb 2026 | tx 14+67,355−19,688 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 1,217 | 50.31 USD | |
| 19 Feb 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 3,258 | 51.27 USD | |
| 19 Feb 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | |
| 19 Feb 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 2,989 | 0.00 USD | deriv |
| 18 Feb 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,977 | 0.00 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 45,000 | 0.00 USD | deriv |
| 14 Aug 2025 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 42.25 USD | |
| 22 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | |
| 22 Feb 2025 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | deriv |
| 19 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 4,475 | 0.00 USD | deriv |
| 19 Feb 2025 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 7,296 | 0.00 USD | deriv |
| 22 Feb 2024 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 8,252 | 0.00 USD | deriv |
| 22 Feb 2024 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 5,369 | 0.00 USD | deriv |
| 17 Aug 2023 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 24,153 | 0.00 USD | deriv |
| 21 Apr 2023 | SALE | Monster Digital, Inc. | 9,100 | 1.21 USD | |
| 27 Mar 2023 | GRANT_AWARD | Monster Digital, Inc. | 50,177 | — | |
| 18 Jan 2022 | GRANT_AWARD | Monster Digital, Inc. | 1,300,000 | 0.00 USD | deriv |